In comparison with non-targeted PMNPs, GE11-conjugated nanocarriers showed a significantly higher internalization into EGFR-overexpressing colorectal cancer cells HCT116 (Figure 5) and higher tumor uptake 24 h post-injection. The gene discussed is EGFR; the disease is colorectal cancer.